Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
GreenBeat is a digital health company that specializes in non-invasive hemodynamic monitoring for patients with chronic cardiovascular conditions, particularly heart failure. The company's core technology utilizes smartphone-based sensors and advanced algorithms to monitor key cardiac parameters such as stroke volume and cardiac output without the need for invasive procedures. By providing real-time data and predictive analytics, GreenBeat aims to enable early detection of clinical deterioration and reduce hospital readmissions. Their solution is designed for remote patient monitoring, allowing healthcare providers to manage high-risk cardiac patients more effectively in a home setting.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Green Beat.